URGN CIK: 1668243

UroGen Pharma Ltd.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.9
FY22:
−87.6
FY23:
−76.4
FY24:
−96.8
FY25:
−162
Change from FY21 to FY25
millions USD
FY21:
4.07
FY22:
1.06
FY23:
−0.95
FY24:
−20.6
FY25:
61.6
Change from FY21 to FY25
millions USD
FY21:
72.3
FY22:
97.1
FY23:
117
FY24:
195
FY25:
39.9
millions USD
FY21:
−8.50
FY22:
10.6
FY23:
39.6
FY24:
77.2
FY25:
−61.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−85.6
FY22:
−87.8
FY23:
−76.6
FY24:
−97.1
FY25:
−163

All amounts in millions USD Data source:SEC EDGAR